Mei-Hua Hall1, Kristina M Holton2, Dost Öngür3, Debra Montrose4, Matcheri S Keshavan5. 1. Psychotic Disorders Division, McLean Hospital HMS, Boston, MA, USA. Electronic address: mhall@mclean.harvard.edu. 2. Department of Research Computing, HMS, Boston, MA, USA. 3. Psychotic Disorders Division, McLean Hospital HMS, Boston, MA, USA. 4. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA. 5. Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Department of Psychiatry, Pittsburgh, PA, USA; Beth Israel Deaconess Medical Center and Massachusetts Mental Health Center, HMS, Boston, MA, USA.
Abstract
BACKGROUND: There is a large variability in the recovery trajectory and outcome of first episode of psychosis [FEP] patients. To date, individuals' outcome trajectories at early stage of illness and potential risk factors associated with a poor outcome trajectory are largely unknown. This study aims to apply three separate predictors (positive symptoms, negative symptoms, and soft neurological signs) to identify homogeneous function outcome trajectories in patients with FEP using objective data-driven methods, and to explore the potential risk /protective factors associated with each trajectory. METHODS: A total of 369 first episode patients (93% antipsychotic naive) were included in the baseline assessments and followed-up at 4-8 weeks, 6 months, and 1 year. K means cluster modeling for longitudinal data (kml3d) was used to identify distinct, homogeneous clusters of functional outcome trajectories. Patients with at least 3 assessments were included in the trajectory analyses (N = 129). The Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS), and Neurological examination abnormalities (NEA) were used as predictors against Global Assessment of Functioning Scale (GAF). RESULTS: In each of the three predictor models, four distinct functional outcome trajectories emerged: "Poor", "Intermediate", High" and "Catch-up". Individuals with male gender; ethnic minority status; low premorbid adjustment; low executive function/IQ, low SES, personality disorder, substance use history may be risk factors for poor recovery. CONCLUSIONS: Functioning recovery in individuals with FEP is heterogeneous, although distinct recovery profiles are apparent. Data-driven trajectory analysis can facilitate better characterization of individual longitudinal patterns of functioning recovery.
BACKGROUND: There is a large variability in the recovery trajectory and outcome of first episode of psychosis [FEP] patients. To date, individuals' outcome trajectories at early stage of illness and potential risk factors associated with a poor outcome trajectory are largely unknown. This study aims to apply three separate predictors (positive symptoms, negative symptoms, and soft neurological signs) to identify homogeneous function outcome trajectories in patients with FEP using objective data-driven methods, and to explore the potential risk /protective factors associated with each trajectory. METHODS: A total of 369 first episode patients (93% antipsychotic naive) were included in the baseline assessments and followed-up at 4-8 weeks, 6 months, and 1 year. K means cluster modeling for longitudinal data (kml3d) was used to identify distinct, homogeneous clusters of functional outcome trajectories. Patients with at least 3 assessments were included in the trajectory analyses (N = 129). The Scale for the Assessment of Negative Symptoms (SANS), Scale for the Assessment of Positive Symptoms (SAPS), and Neurological examination abnormalities (NEA) were used as predictors against Global Assessment of Functioning Scale (GAF). RESULTS: In each of the three predictor models, four distinct functional outcome trajectories emerged: "Poor", "Intermediate", High" and "Catch-up". Individuals with male gender; ethnic minority status; low premorbid adjustment; low executive function/IQ, low SES, personality disorder, substance use history may be risk factors for poor recovery. CONCLUSIONS: Functioning recovery in individuals with FEP is heterogeneous, although distinct recovery profiles are apparent. Data-driven trajectory analysis can facilitate better characterization of individual longitudinal patterns of functioning recovery.
Authors: Matcheri S Keshavan; Harpreet S Duggal; Gautami Veeragandham; Nancy M McLaughlin; Debra M Montrose; Gretchen L Haas; Nina R Schooler Journal: Am J Psychiatry Date: 2005-01 Impact factor: 18.112
Authors: William G Honer; Andrea A Jones; Allen E Thornton; Alasdair M Barr; Ric M Procyshyn; Fidel Vila-Rodriguez Journal: Can J Psychiatry Date: 2015-03 Impact factor: 4.356
Authors: Kim T Mueser; David L Penn; Arundati Nagendra; David M Weiss; Carrington Merritt; Corinne Cather; Effua E Sosoo Journal: Soc Psychiatry Psychiatr Epidemiol Date: 2022-08-06 Impact factor: 4.519
Authors: Dominic B Dwyer; Janos L Kalman; Monika Budde; Joseph Kambeitz; Anne Ruef; Linda A Antonucci; Lana Kambeitz-Ilankovic; Alkomiet Hasan; Ivan Kondofersky; Heike Anderson-Schmidt; Katrin Gade; Daniela Reich-Erkelenz; Kristina Adorjan; Fanny Senner; Sabrina Schaupp; Till F M Andlauer; Ashley L Comes; Eva C Schulte; Farah Klöhn-Saghatolislam; Anna Gryaznova; Maria Hake; Kim Bartholdi; Laura Flatau-Nagel; Markus Reitt; Silke Quast; Sophia Stegmaier; Milena Meyers; Barbara Emons; Ida Sybille Haußleiter; Georg Juckel; Vanessa Nieratschker; Udo Dannlowski; Tomoya Yoshida; Max Schmauß; Jörg Zimmermann; Jens Reimer; Jens Wiltfang; Eva Reininghaus; Ion-George Anghelescu; Volker Arolt; Bernhard T Baune; Carsten Konrad; Andreas Thiel; Andreas J Fallgatter; Christian Figge; Martin von Hagen; Manfred Koller; Fabian U Lang; Moritz E Wigand; Thomas Becker; Markus Jäger; Detlef E Dietrich; Harald Scherk; Carsten Spitzer; Here Folkerts; Stephanie H Witt; Franziska Degenhardt; Andreas J Forstner; Marcella Rietschel; Markus M Nöthen; Nikola Mueller; Sergi Papiol; Urs Heilbronner; Peter Falkai; Thomas G Schulze; Nikolaos Koutsouleris Journal: JAMA Psychiatry Date: 2020-05-01 Impact factor: 21.596
Authors: Els van der Ven; Jennifer Scodes; Cale Basaraba; Luca Pauselli; Franco Mascayano; Ilana Nossel; Iruma Bello; Jennifer Humensky; Ezra Susser; Melanie Wall; Lisa Dixon Journal: Schizophr Res Date: 2020-06-05 Impact factor: 4.939
Authors: Kyle R Roell; Quaker E Harmon; Kari Klungsøyr; Anna E Bauer; Per Magnus; Stephanie M Engel Journal: Hypertension Date: 2021-04-05 Impact factor: 9.897
Authors: Shaunagh O'Sullivan; Lianne Schmaal; Simon D'Alfonso; Yara Jo Toenders; Lee Valentine; Carla McEnery; Sarah Bendall; Barnaby Nelson; John F Gleeson; Mario Alvarez-Jimenez Journal: JMIR Ment Health Date: 2022-04-07